Sellers starting to dry up and good move above $2 today.
With end of quarter closing in some good sales data will give it the boost it needs.
I am surprised CST has not been attracting more interest from those looking for a defensive position with growth propects at this time of uncertainty. Perhaps our financial adviser friends need to take a better look at Cellestis.
The $1.85 buy is starting to look alright Lopez.
candy, page-17
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
